Argon Medical Devices
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Argon Medical Devices sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Argon Medical Devices: 4 sponsored US clinical trials, 2 recruiting.
Argon Medical Devices sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts, with 1 trials.
Upper-quartile sponsor footprint
Argon Medical Devices sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
NCT07102160
CLEANer Aspiration for Pulmonary Embolism
NCT06189313
Achieving Portal Access With Scorpion Post-Approval Study (APASS)
NCT05765253
Achieving Portal Access With Scorpion Post-Approval Study 2
NCT06856655
Therapeutic Areas
What is open in the Argon Medical Devices pipeline
2 recruiting of 4 indexed (50% open); 1 completed (25%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts (1 trial), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Argon Medical Devices: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Argon Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this Argon Medical Devices page
4 registered trials is a research-attention snapshot, not an endorsement of Argon Medical Devices or any single study.
- 2 of Argon Medical Devices's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts is the condition Argon Medical Devices studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Argon Medical Devices pipeline card: 4 registered trials from official public datasets.Report a data error.